- Home
- APLS vs RLX Comparison
APLS vs RLX Comparison
Compare APLS & RLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- RLX
- Stock Information
- Founded
- APLS 2009
- RLX 2018
- Country
- APLS United States
- RLX China
- Employees
- APLS N/A
- RLX N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- RLX Medicinal Chemicals and Botanical Products
- Sector
- APLS Health Care
- RLX Health Care
- Exchange
- APLS Nasdaq
- RLX Nasdaq
- Market Cap
- APLS 2.9B
- RLX 2.8B
- IPO Year
- APLS 2017
- RLX 2021
- Fundamental
- Price
- APLS $28.21
- RLX $2.43
- Analyst Decision
- APLS Buy
- RLX Hold
- Analyst Count
- APLS 19
- RLX 1
- Target Price
- APLS $33.63
- RLX $2.25
- AVG Volume (30 Days)
- APLS 2.4M
- RLX 2.1M
- Earning Date
- APLS 10-30-2025
- RLX 11-14-2025
- Dividend Yield
- APLS N/A
- RLX 0.41%
- EPS Growth
- APLS N/A
- RLX 12.15
- EPS
- APLS N/A
- RLX 0.08
- Revenue
- APLS $754,649,000.00
- RLX $407,348,055.00
- Revenue This Year
- APLS $24.62
- RLX $59.70
- Revenue Next Year
- APLS N/A
- RLX $27.15
- P/E Ratio
- APLS N/A
- RLX $31.14
- Revenue Growth
- APLS 20.02
- RLX 55.36
- 52 Week Low
- APLS $16.10
- RLX $1.57
- 52 Week High
- APLS $35.72
- RLX $2.84
- Technical
- Relative Strength Index (RSI)
- APLS 64.41
- RLX 50.81
- Support Level
- APLS $23.85
- RLX $2.31
- Resistance Level
- APLS $25.73
- RLX $2.42
- Average True Range (ATR)
- APLS 1.28
- RLX 0.06
- MACD
- APLS 0.51
- RLX -0.01
- Stochastic Oscillator
- APLS 87.59
- RLX 58.54
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share
RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.